These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 31286349

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.
    Gatidis S, Schmidt H, la Fougère C, Nikolaou K, Schwenzer NF, Schäfer JF.
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.
    Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SCJ, van Berckel BNM, Ossenkoppele R, Barkhof F, Larsson EM.
    Eur Radiol; 2017 Oct; 27(10):4237-4246. PubMed ID: 28374078
    [Abstract] [Full Text] [Related]

  • 6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 7. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
    Musiek ES, Saboury B, Mishra S, Chen Y, Reddin JS, Newberg AB, Udupa JK, Detre JA, Hofheinz F, Torigian D, Alavi A.
    Hell J Nucl Med; 2012 May; 15(3):190-6. PubMed ID: 23106049
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    Tripathi M, Tripathi M, Damle N, Kushwaha S, Jaimini A, D'Souza MM, Sharma R, Saw S, Mondal A.
    Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.
    Anazodo UC, Finger E, Kwan BYM, Pavlosky W, Warrington JC, Günther M, Prato FS, Thiessen JD, St Lawrence KS.
    Neuroimage Clin; 2018 Feb; 17():405-414. PubMed ID: 29159053
    [Abstract] [Full Text] [Related]

  • 12. Feasibility of 18F-FDG Dose Reductions in Breast Cancer PET/MRI.
    Sah BR, Ghafoor S, Burger IA, Ter Voert EEGW, Sekine T, Delso G, Huellner M, Dedes KJ, Boss A, Veit-Haibach P.
    J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
    [Abstract] [Full Text] [Related]

  • 13. Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model.
    Gjerum L, Frederiksen KS, Henriksen OM, Law I, Bruun M, Simonsen AH, Mecocci P, Baroni M, Dottorini ME, Koikkalainen J, Lötjönen J, Hasselbalch SG.
    Neuroimage Clin; 2020 Dec; 27():102267. PubMed ID: 32417727
    [Abstract] [Full Text] [Related]

  • 14. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
    Rostomian AH, Madison C, Rabinovici GD, Jagust WJ.
    J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181
    [Abstract] [Full Text] [Related]

  • 15. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
    Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA.
    Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
    [Abstract] [Full Text] [Related]

  • 16. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
    Jena A, Taneja S, Goel R, Renjen P, Negi P.
    Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    Moodley KK, Perani D, Minati L, Della Rosa PA, Pennycook F, Dickson JC, Barnes A, Contarino VE, Michopoulou S, D'Incerti L, Good C, Fallanca F, Vanoli EG, Ell PJ, Chan D.
    J Alzheimers Dis; 2015 Jul; 46(3):639-53. PubMed ID: 26402512
    [Abstract] [Full Text] [Related]

  • 18. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A.
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [Abstract] [Full Text] [Related]

  • 19. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
    Shepherd TM, Nayak GK.
    Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.